Cardiolipin Antibody (IgM) – Phospholipid-Associated Autoantibody Test
This test measures the presence of IgM antibodies against cardiolipin, a phospholipid found in cell membranes. These antibodies may be linked to certain autoimmune conditions or blood clotting disorders.
["This test helps evaluate potential autoimmune or clotting risks by detecting unusual antibody activity against a common cell component."]
Key facts at a glance
- LOINC
- 42733-6
- Short code
- CARDIOM
- Synonyms
- Cardiolipin IgM B2GP1 dep MoM Ser
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) - red top with gel separator
- Units
- N/A
- Ref low
- 0
- Ref high
- 19.9
- Critical range
- — – 80 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunoassay (ELISA) for beta-2 glycoprotein 1-dependent cardiolipin IgM antibodies, results expressed as Multiple of the Median (MoM)
- CPT
- 86147
- SNOMED
- 439171006
- Specimen volume
- 1.0 mL serum (minimum 0.5 mL)
- Stability
- Room temperature: 8 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 6 months. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 100
- Lipemia max
- 50
- Icterus max
- 50
- TAT
- 24–72 hours
- Order
- routine
What This Test Measures
Cardiolipin is a phospholipid naturally present in cell membranes, including those in blood vessels. When the immune system mistakenly targets these molecules, it may produce antibodies like IgM cardiolipin antibodies. This test checks for their presence in your blood.
Why It Might Be Ordered
Your healthcare provider may recommend this test if you have symptoms like unexplained bruising, blood clots, or autoimmune conditions (e.g., lupus, antiphospholipid syndrome). It can also be part of screening for conditions affecting blood flow or clotting mechanisms.
Sample Collection and Preparation
A blood sample is drawn from a vein, typically in your arm. The blood is processed to separate serum (the liquid part after clotting). This serum is then tested for IgM antibodies against cardiolipin using a sensitive laboratory method.
What to Expect Before the Test
No special preparation is needed, but inform your provider about any medications (e.g., blood thinners) or recent illnesses that might affect results. Avoid alcohol or strenuous activity 24 hours before testing if instructed.
Reference range
< 20 MPL (negative); 20-39.9 MPL (low-positive); 40-79.9 MPL (medium-positive); ≥ 80 MPL (high-positive). Results expressed as Multiple of the Median (MoM) relative to a reference population median.N/A
No fasting required. Patient should be well-hydrated. Avoid testing during acute illness or inflammation as this may cause transient elevations.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Positive results may indicate an autoimmune response, potentially linked to conditions like antiphospholipid syndrome (APS), which can increase clot risk. While elevated antibodies don’t always mean a diagnosis, they may prompt further evaluation for underlying causes. Always discuss results with your provider.
Short name
IgM Cardiolipin Antibody
Frequently asked questions
What does a positive result mean?
Can lifestyle changes affect this test?
How often might I need this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy